What is the typical dosage of Macrobid (nitrofurantoin) for uncomplicated urinary tract infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Macrobid (Nitrofurantoin) Dosing for Uncomplicated UTI

For uncomplicated urinary tract infections in women, the standard dose of Macrobid (nitrofurantoin monohydrate/macrocrystals) is 100 mg twice daily for 5-7 days. 1

Standard Dosing Regimen

  • The Infectious Diseases Society of America (IDSA) and European Society for Microbiology and Infectious Diseases (ESMID) recommend 100 mg twice daily for 5 days as the optimal first-line regimen for uncomplicated UTIs in women. 1

  • The European Association of Urology similarly endorses 100 mg twice daily for 5 days as first-line therapy for uncomplicated cystitis. 1

  • This 5-day regimen achieves clinical cure rates of 88-93% and bacterial cure rates of 81-92%. 1

Efficacy Compared to Alternatives

  • The 5-day nitrofurantoin regimen (100 mg twice daily) demonstrates equivalent efficacy to trimethoprim-sulfamethoxazole (160/800 mg twice daily for 3 days) in both clinical and microbiological cure rates. 1

  • In a head-to-head trial, 5-day nitrofurantoin achieved 84% clinical resolution at 28 days compared to 58% with single-dose fosfomycin, representing a statistically significant 12% absolute difference (P = 0.004). 2

  • When compared to 7-day regimens of ciprofloxacin and trimethoprim-sulfamethoxazole, nitrofurantoin shows similar clinical cure rates. 1

Alternative Dosing Schedules

  • For vancomycin-resistant Enterococci (VRE) UTIs specifically, increase the dose to 100 mg four times daily. 1

  • The macrocrystal formulation can alternatively be dosed at 50-100 mg four times daily for 5 days, though the twice-daily regimen is preferred for adherence. 1

  • Treatment duration can range from 3-7 days, though 5 days is the evidence-based standard. 1

Critical Contraindications and Warnings

  • Avoid nitrofurantoin if early pyelonephritis is suspected, as inadequate tissue penetration may lead to treatment failure. 1

  • Nitrofurantoin is contraindicated when creatinine clearance is <60 mL/min due to inadequate urinary drug concentrations and increased risk of peripheral neuropathy. 3

  • In males with UTI, nitrofurantoin has substantially lower efficacy (25% failure rate) compared to females (10-16% failure rate), making it a less optimal choice for men. 3

Common Pitfalls to Avoid

  • Do not use 3-day regimens despite some UK guidelines recommending this duration—there is insufficient direct evidence supporting 3-day courses, and the established 5-day regimen has superior evidence. 4

  • Do not extend treatment beyond 7 days unless symptoms persist, as shorter courses minimize adverse effects while maintaining efficacy. 1

  • For males requiring nitrofurantoin, use 100 mg every 6 hours (four times daily) for 7-14 days, with 14 days recommended when prostatitis cannot be excluded. 3

Side Effect Profile

  • Nausea and headache are the most commonly reported side effects. 1

  • Adverse event rates range from 5.6-34% across studies, with gastrointestinal symptoms (nausea 3%, diarrhea 1%) being most frequent. 1, 2

  • The safety profile is favorable with minimal cross-reactivity with other antibiotic classes. 5

When to Choose Alternatives

  • If the patient has multiple antibiotic allergies including nitrofurantoin, fosfomycin trometamol 3 g single dose is the preferred alternative. 5

  • If local E. coli resistance to trimethoprim-sulfamethoxazole is <20%, this becomes a viable 3-day alternative. 1

  • Reserve fluoroquinolones as last-resort options due to resistance concerns and adverse effect profiles. 1, 5

References

Guideline

Nitrofurantoin Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nitrofurantoin Dosing for Male UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nitrofurantoin: what is the evidence for current UK guidance?

The Journal of antimicrobial chemotherapy, 2023

Guideline

Treatment Options for Cystitis in Patients with Multiple Antibiotic Allergies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.